Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics.

Abstract	Current studies concerning myotonic dystrophy type 1 (DM1) are in the process of transitioning from molecular investigations to preclinical and clinical trials [...].
Authors	Lubov Timchenko
Journal	International journal of molecular sciences (Int J Mol Sci) Vol. 23 Issue 19 (Oct 08 2022) ISSN: 1422-0067 [Electronic] Switzerland
PMID	36233257 (Publication Type: Editorial)
Topics	Humans Myotonic Dystrophy (drug therapy, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!